Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
6(100.0%)
6Total
N/A(6)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT01645345Not ApplicableCompleted

Fractional Ablative Radiofrequency for the Treatment of Acne Scars and Wrinkles

Role: lead

NCT04519723Not ApplicableCompleted

Laser 360iQ: Optimal Light-laser Combination Therapy

Role: lead

NCT04519736Not ApplicableCompleted

Single Band vs. Dual Band Pulsed Light Technology for the Treatment of Photodamage - A Split Face Comparison Study

Role: lead

NCT03115944Not ApplicableUnknown

Pro00019086 - Ultra Circumference Reduction

Role: lead

NCT02747641Not ApplicableCompleted

Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects

Role: lead

NCT01847066Not ApplicableUnknown

Epidermal Delivery of Ani-Aging Ingredients

Role: lead

All 6 trials loaded